SYNVISC ONE

Synvisc ONE Injection is a form of hyaluronan, which is a sodium salt derived from hyaluronic acid. Hyaluronan plays a crucial role in synovial fluid, the substance that provides viscosity in joints and aids in movement. The Synvisc one injection polymer A&B G-F 20 is administered as an intra-articular injection for individuals suffering from knee osteoarthritis. Its purpose is to alleviate pain and discomfort linked to knee issues by serving as a temporary substitute for synovial fluid, benefiting those who frequently use the affected knee. This injection can be utilized on its own or alongside other medications. Avoid using this medication if you have an allergy to Proteolytic or any of its components.

Before receiving Synvisc Injection, inform your doctor if you are pregnant, planning to conceive, or breastfeeding. Discuss with your healthcare provider all medications you have taken recently, including supplements and herbal products. Alert your doctor if you have an infection in the knee joint, a skin condition or infection at the injection site, or any bleeding disorders. Prior to receiving Synvisc one, inform your doctor if you experience severe knee inflammation, lymphatic or venous stasis (swelling or inflammation) in the leg designated for injection, or chondrocalcinosis (the presence of calcium pyrophosphate dihydrate crystals in and around the joints). There is limited information regarding the use of Synvisc injection in children. In older adults, this medication should be administered with caution. For further details, consult your physician. If you are seeking alternatives to the Synvisc-one injection, please reach out to your doctor.